A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Cancer
B G Durie, S E Salmon

Abstract

The presenting clinical features of 71 patients with multiple myeloma were correlated with myeloma cell mass (myeloma cells X 10(12)/m2 of body surface area) determined from measurements of monoclonal immunoglobulin (M-component) synthesis and metabolism. Bivariate correlation and multivariate regression analyses showed that myeloma cell mass could be accurately predicted from A) extent of bone lesions, B) hemoglobin level, C) serum calcium level, and D) M-component levels in serum and urine. Analyses of response to chemotherapy and survival indicated significant correlation with measured myeloma cell burden. The results were synthesized to produce a very reliable and useful clinical staging system with three tumor cell mass levels (Table 7). For clinical research purposes, multivariate regression equations were developed to predict optimally the exact myeloma cell mass. Thus, initial staging can be quantitatively related to followup using tumor cell mass changes calculated from changes in M-component production. Use of the clinical staging system sould provide better initial assessment and followup of individual patients, and should lead to improved study design and analysis in large clinical trials of therapy for multiple mye...Continue Reading

References

Jan 1, 1975·Archives of Internal Medicine·D E Bergsagel, W Pruzanski
Aug 1, 1967·The Journal of Experimental Medicine·R D WochnerT A Waldmann
Jun 1, 1969·British Journal of Haematology·J R Hobbs
Dec 1, 1972·Cancer·D E Bergsagel
Apr 18, 1974·The New England Journal of Medicine·S Hellman
Aug 1, 1974·Cancer·J E Meyer, M D Schulz
Nov 18, 1974·JAMA : the Journal of the American Medical Association·H E Skipper
Dec 15, 1973·British Medical Journal·R B PayneJ R Milner
Jan 1, 1973·Scandinavian Journal of Haematology·O P HansenA Videbaek
Apr 1, 1974·Journal of the National Cancer Institute·V K Ghanta, R N Hiramoto
Jan 1, 1967·Advances in Cancer Research·D E BergsagelW J Stuckey
Jun 1, 1970·The Journal of Clinical Investigation·S E Salmon, B A Smith
May 1, 1971·The Medical Clinics of North America·B J LeeD G Miller
Jul 1, 1972·The Journal of Clinical Investigation·P W Sullivan, S E Salmon
Oct 1, 1971·Postgraduate Medical Journal·A A Dawson, D Ogston
May 8, 1971·British Medical Journal·R Peto
May 8, 1971·British Medical Journal·B Johansson
Aug 1, 1967·Proceedings of the Society for Experimental Biology and Medicine·Y MatsuokaD Pressman
Jul 1, 1958·The Journal of Experimental Medicine·D NATHANSM POTTER
Jan 1, 1964·The Journal of Clinical Investigation·A SOLOMONA S MCFARLANE
Apr 16, 1965·Science·D E DE BERGSAGELK M GRIFFITH
Jul 30, 1965·Science·L MAFFEIG RIZZOLATTI

❮ Previous
Next ❯

Citations

Apr 22, 1999·Bulletin du cancer·P MoreauJ L Harousseau
Apr 18, 2001·International Journal of Cancer. Journal International Du Cancer·C ZhengA Sundblad
May 10, 2002·Cancer·Motoaki ShiratsuchiJunji Nishimura
May 1, 1992·Hematological Oncology·G UcciM Danova
Mar 1, 1995·Hematological Oncology·P W ThavasuF R Balkwill
Sep 1, 1995·Medicinal Research Reviews·G C ViscomiS Silvestri
May 19, 2000·Cell Biology International·K GadóA Falus
Jan 1, 1984·Cancer Immunology, Immunotherapy : CII·L BergmannW Kelker
Jan 1, 1982·Cancer Chemotherapy and Pharmacology·G MerliniS Perugini
Jul 1, 1982·Blut·O P Hansen, A Drivsholm
Jan 1, 1986·Skeletal Radiology·J I SebesT J Reidy
Jan 1, 1983·Journal of Cancer Research and Clinical Oncology·H G Hokamp, E Grundmann
Jan 1, 1980·Virchows Archiv. A, Pathological Anatomy and Histology·M MelatoA Pezzoli
Jan 9, 1992·British Journal of Hospital Medicine·D A Winfield
Jan 1, 1988·European Journal of Clinical Pharmacology·U LoosH J Dengler
Jan 1, 1989·Cancer Immunology, Immunotherapy : CII·D PeestH Deicher
Jan 1, 1993·International Journal of Clinical & Laboratory Research·C R Tillyer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.